|
Apr 10
|
Moderna (MRNA) Surges 6.2%: Is This an Indication of Further Gains?
|
|
Apr 1
|
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
|
|
Mar 25
|
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist
|
|
Mar 22
|
Chief Technical Officer Joseph Shulman Sells 18,235 Shares of Rhythm Pharmaceuticals Inc (RYTM)
|
|
Mar 20
|
Insider Sell: Rhythm Pharmaceuticals Inc (RYTM) CEO David Meeker Disposes of 45,494 Shares
|
|
Mar 20
|
Insider Sell: Chief Technical Officer Joseph Shulman Sells 15,515 Shares of Rhythm ...
|
|
Mar 20
|
Insider Sell: CFO Hunter Smith Sells 15,515 Shares of Rhythm Pharmaceuticals Inc (RYTM)
|
|
Mar 6
|
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences
|
|
Dec 30
|
Insider Sell: Rhythm Pharmaceuticals CTO Joseph Shulman Sells 12,941 Shares
|
|
Dec 8
|
Insider Sell Alert: CFO Hunter Smith Sells 27,026 Shares of Rhythm Pharmaceuticals Inc (RYTM)
|
|
Dec 6
|
Rhythm Pharmaceuticals Announces Updates on MC4R Pathway Programs at R&D Event
|
|
Nov 7
|
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Tops Revenue Estimates
|
|
Nov 7
|
Rhythm Pharmaceuticals Inc (RYTM) Reports Q3 2023 Financial Results
|
|
Nov 7
|
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
|
|
Nov 2
|
Rhythm Pharmaceuticals Receives Positive CADTH Reimbursement Recommendation for IMCIVREE® (setmelanotide)
|
|
Sep 8
|
EVP Jennifer Lee Sells 6,166 Shares of Rhythm Pharmaceuticals Inc (RYTM)
|
|
Sep 8
|
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
|
|
Sep 8
|
Rhythm Pharmaceuticals Announces Update to September Conference Participation
|
|
Sep 6
|
Rhythm Pharmaceuticals Announces New ICD-10 Diagnosis Code Established for Bardet-Biedl Syndrome
|
|
Jul 19
|
Rhythm Pharmaceuticals Announces Two Publications Detailing Burden of Hyperphagia and Obesity on Patients and Caregivers Living with Bardet-Biedl Syndrome
|